AFG
DGX icon

Atomi Financial Group’s Quest Diagnostics DGX Stock Holding History

Atomi Financial Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$706K Buy
3,601
+19
+0.5% +$3.69K 0.02% 560
2025
Q4 		$622K Buy
3,582
+2,254
+170% +$410K 0.02% 597
2025
Q3 		$253K Buy
+1,328
New +$236K 0.01% 985

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Atomi Financial Group's DGX Position: Q1 2026 in Review

Atomi Financial Group increased its Quest Diagnostics (DGX) stake by 0.53% in Q1 2026, buying an estimated $3.69K and bringing the position to 3,601 shares worth $706K. The position accounts for 0.02% of the portfolio, ranked #560.

Atomi Financial Group first reported a position in DGX in Q3 2025 and has held it in 3 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Atomi Financial Group held 3,601 shares of Quest Diagnostics worth $706K as of Q1 2026.
  • Atomi Financial Group bought 19 Quest Diagnostics shares in Q1 2026, an estimated $3.69K.
  • Quest Diagnostics made up 0.02% of Atomi Financial Group's portfolio in Q1 2026, its #560 holding.
  • Atomi Financial Group first reported a position in Quest Diagnostics in Q3 2025 and has held it in 3 quarters since.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.